RGS 0.00% 12.0¢ regeneus ltd

The Australian Football League’s approval for the case-by-case...

  1. The Australian Football League’s approval for the case-by-case use of Regeneus HiQCell® stem cell therapy to treat injured players is a significant step forward for Regeneus with a high profile sporting authority. The regenerative therapy has also received clearance from the Australian Sports Anti-Doping Authority.

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.